Literature DB >> 10455881

Relationship between hospital volume and late survival after pancreaticoduodenectomy.

J D Birkmeyer1, A L Warshaw, S R Finlayson, M R Grove, A N Tosteson.   

Abstract

BACKGROUND: Several studies have reported lower perioperative mortality rates with pancreaticoduodenectomy at high-volume hospitals than at low-volume hospitals. We sought to determine whether volume is also related to survival after hospital discharge.
METHODS: Using information from the Medicare claims database, we performed a retrospective cohort study of all 7229 patients over age 65 undergoing pancreaticoduodenectomy in the United States between 1992 and 1995. We divided the study population into approximate quartiles according to their hospital's average annual volume of pancreaticoduodenectomies in Medicare patients: very low (< 1/y), low (1-2/y, medium (2-5/y), and high (5+/y). To adjust for potentially confounding variables, we used a Cox proportional hazards model to examine relationships between hospital volume and mortality, our primary outcome measure.
RESULTS: Overall, 3-year survival was higher at high-volume centers (37%) than at medium- (29%), low- (26%), and very low volume hospitals (25%) (log-rank P < .0001). After excluding perioperative deaths and adjusting for case-mix, patients undergoing surgery at high-volume hospitals remained less likely to experience late mortality than patients at very low volume centers (adjusted hazard ratio 0.69, 95% CI 0.62-0.76). Relationships between hospital volume and survival after discharge were not restricted to patients with cancer diagnoses; patients with benign disease had similar improvements in late survival after surgery at high-volume centers.
CONCLUSIONS: Hospital volume strongly influences both perioperative risk and long-term survival after pancreaticoduodenectomy. Our data suggest that both patient selection and differences in quality of care may underlie better outcomes at high-volume referral centers.

Entities:  

Mesh:

Year:  1999        PMID: 10455881

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  87 in total

1.  Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

Authors:  Ross A Abrams; Kathryn A Winter; William F Regine; Howard Safran; John P Hoffman; Robert Lustig; Andre A Konski; Al B Benson; John S Macdonald; Tyvin A Rich; Christopher G Willett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-01       Impact factor: 7.038

2.  The volume-outcome relationship in cancer surgery: a hard sell.

Authors:  Ingemar Ihse
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

3.  Surgical education in the United States: portents for change.

Authors:  Murray F Brennan; Haile T Debas
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

4.  Pancreaticoduodenectomy in a government medical college-should we proceed!!!

Authors:  Devi Prasad Patra; Abhimanyu Basu; Susnata De; Shivam Vatsal
Journal:  Indian J Surg       Date:  2010-11-16       Impact factor: 0.656

5.  Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study.

Authors:  Parul J Shukla; Savio G Barreto; Mms Bedi; N Bheerappa; Adarsh Chaudhary; Md Gandhi; M Jacob; S Jesvanth; Dg Kannan; Vinay K Kapoor; A Kumar; Kk Maudar; Hariharan Ramesh; Ra Sastry; Rajan Saxena; Ajit Sewkani; S Sharma; Shailesh V Shrikhande; A Singh; Rajneesh K Singh; R Surendran; Subodh Varshney; V Verma; V Vimalraj
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

6.  Early perioperative outcomes and pancreaticoduodenectomy in a general surgery residency training program.

Authors:  Craig P Fischer; Johnny C Hong
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

Review 7.  Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Authors:  H G Smeenk; T C K Tran; J Erdmann; C H J van Eijck; J Jeekel
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

8.  Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?

Authors:  Alexander L Lazarides; David L Kerr; Daniel P Nussbaum; R Timothy Kreulen; Jason A Somarelli; Dan G Blazer; Brian E Brigman; William C Eward
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

9.  Institutional clinical trial accrual volume and survival of patients with head and neck cancer.

Authors:  Evan J Wuthrick; Qiang Zhang; Mitchell Machtay; David I Rosenthal; Phuc Felix Nguyen-Tan; André Fortin; Craig L Silverman; Adam Raben; Harold E Kim; Eric M Horwitz; Nancy E Read; Jonathan Harris; Qian Wu; Quynh-Thu Le; Maura L Gillison
Journal:  J Clin Oncol       Date:  2014-12-08       Impact factor: 44.544

10.  Necrotizing soft-tissue infections: differences in patients treated at burn centers and non-burn centers.

Authors:  Frederick W Endorf; Matthew B Klein; Christopher D Mack; Gregory J Jurkovich; Frederick P Rivara
Journal:  J Burn Care Res       Date:  2008 Nov-Dec       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.